Daniel George Wildman - 08 Nov 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
08 Nov 2022
Net transactions value
$0
Form type
4
Filing time
09 Nov 2022, 16:57:03 UTC
Next filing
08 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 08 Nov 2022 Ordinary Shares 20,000 $11.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest in equal quarterly installments for 12 quarters